These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recurrent ventricular tachycardia in malignant metastatic pheochromocytoma. Park JW; Park SJ; Hur KY; Kim JH; Choi YL; Park SM; Kim SM; Koo EH; Kim JS Circulation; 2012 Mar; 125(10):e435-8. PubMed ID: 22412096 [No Abstract] [Full Text] [Related]
4. [Pheochromocytoma. A case report]. Garritano A; Ceraudo E; De Rose F; Jantosca F; Santarelli E; Taccaliti F Minerva Chir; 1999 Apr; 54(4):283-6. PubMed ID: 10380530 [TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma: unusual presentation of a rare disease. Hamdan A; Hirsch D; Green P; Neumann A; Drozd T; Molad Y Isr Med Assoc J; 2002 Oct; 4(10):827-8. PubMed ID: 12389354 [No Abstract] [Full Text] [Related]
6. Epinephrine producing pheochromocytoma. Is the secretory pattern decisive for the clinical manifestation? Lipsic E; Balazovjech I; Kosmálová V; Makaiová I; Dekrét J; Zanou DF J Endocrinol Invest; 2004; 27(7):691-4. PubMed ID: 15505997 [TBL] [Abstract][Full Text] [Related]
7. [Malignant pheochromocytoma. A case report and comments on a rare pathology]. Boneschi M; Erba M; Rinaldi P; Cusmai F; Miani S Minerva Chir; 1999; 54(1-2):73-8. PubMed ID: 10230231 [TBL] [Abstract][Full Text] [Related]
9. Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma. Pontremoli R; Borgonovo G; Ranise A; Garibotto G J Endocrinol Invest; 1989 Oct; 12(9):647-9. PubMed ID: 2685095 [TBL] [Abstract][Full Text] [Related]
10. [Pheochromocytoma: role of preoperative diagnosis in the assessment of malignancy risk and in the choice of surgical approach]. Lombardi CP; Raffaelli M; De Crea C; Traini E; D'Amore AM; Bellantone R Suppl Tumori; 2005; 4(3):S211. PubMed ID: 16437995 [TBL] [Abstract][Full Text] [Related]
11. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma. Greenblatt DY; Shenker Y; Chen H Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324 [TBL] [Abstract][Full Text] [Related]
12. [Pheochromocytoma can be an insidious disease]. Paronen J; Väisänen M; Leijon H Duodecim; 2013; 129(22):2375-8. PubMed ID: 24397150 [TBL] [Abstract][Full Text] [Related]
13. [Problems posed by asymptomatic pheochromocytoma and malignant tumors of the adrenal medulla]. Zvara V; Pauer M; Balazovjech I; Kreze A; Májek M; Breza J Ann Urol (Paris); 1996; 30(1):14-9. PubMed ID: 8712755 [TBL] [Abstract][Full Text] [Related]
15. Malignant pheochromocytoma lacking clinical features of catecholamine excess until the late stage. Honda M; Uesugi K; Yamazaki H; Dezawa A; Mizuguchi K; Yamaji T; Ishibashi M Intern Med; 2000 Oct; 39(10):820-5. PubMed ID: 11030207 [TBL] [Abstract][Full Text] [Related]
16. [A comparative study of 9 cases of adrenal pheochromocytoma and 11 cases of extra-adrenal pheochromocytoma]. Mediavilla García JD; López de la Torre Casares M; Hidalgo Tenorio C; Fernández-Torres C; Aliaga Martínez L; Peran Mesa F; Muros de Fuentes MA Rev Clin Esp; 1999 Jun; 199(6):343-8. PubMed ID: 10432807 [TBL] [Abstract][Full Text] [Related]
17. Lack of symptoms in patients with histologic evidence of pheochromocytoma: a diagnostic challenge. Cohen DL; Fraker D; Townsend RR Ann N Y Acad Sci; 2006 Aug; 1073():47-51. PubMed ID: 17102071 [TBL] [Abstract][Full Text] [Related]